GSK plc Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-06-10: Form 6-K; Period of report 2025-06-10; Description TRANSACTION IN OWN SHARES; Document a0857m.htm.
- 2025-06-09: Form 6-K; Period of report 2025-06-09; Description TRANSACTION IN OWN SHARES; Document a8928l.htm.
- 2025-06-06: Form 6-K; Period of report 2025-06-06; Description TRANSACTION IN OWN SHARES; Document a7005l.htm.
- 2025-06-05: Form 6-K; Period of report 2025-06-05; Description TRANSACTION IN OWN SHARES; Document a4995l.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2025-06-10 | 6-K | 2025-06-10 | TRANSACTION IN OWN SHARES | a0857m.htm |
| 2025-06-09 | 6-K | 2025-06-09 | TRANSACTION IN OWN SHARES | a8928l.htm |
| 2025-06-06 | 6-K | 2025-06-06 | TRANSACTION IN OWN SHARES | a7005l.htm |
| 2025-06-05 | 6-K | 2025-06-05 | TRANSACTION IN OWN SHARES | a4995l.htm |
| 2025-06-04 | 6-K | 2025-06-04 | GSK - SECOND TRANCHE OF SHARE BUYBACK PROGRAMME | a2986l.htm |
| 2025-06-04 | 6-K | 2025-06-04 | TRANSACTION IN OWN SHARES | a2964l.htm |
| 2025-06-03 | 6-K | 2025-06-03 | TRANSACTION IN OWN SHARES | a1055l.htm |
| 2025-06-02 | 6-K | 2025-06-02 | DIRECTOR/PDMR SHAREHOLDING | a0607l.htm |
| 2025-06-02 | 6-K | 2025-06-02 | TOTAL VOTING RIGHTS | a0706l.htm |
| 2025-06-02 | 6-K | 2025-06-02 | LINERIXIBAT FILE ACCEPTED FOR REVIEW BY US FDA | a8978k.htm |
| 2025-06-02 | 6-K | 2025-06-02 | TRANSACTION IN OWN SHARES | a8872k.htm |
| 2025-05-30 | 6-K | 2025-05-30 | TRANSACTION IN OWN SHARES | a6901k.htm |
| 2025-05-29 | 6-K | 2025-05-29 | TRANSACTION IN OWN SHARES | a4957k.htm |
| 2025-05-28 | 6-K | 2025-05-28 | GSK STOPS PHASE 3 TRIAL ON CUTIS FOR EFFICACY | a4074k.htm |
| 2025-05-28 | 6-K | 2025-05-28 | TRANSACTION IN OWN SHARES | a3035k.htm |
| 2025-05-27 | 6-K | 2025-05-27 | TRANSACTION IN OWN SHARES | a0680k.htm |
| 2025-05-23 | 6-K | 2025-05-23 | POSITIVE CHMP OPINION ON BLENREP IN EU | a9818j.htm |
| 2025-05-23 | 6-K | 2025-05-23 | FDA APPROVES NUCALA COPD INDICATION | a8776j.htm |
| 2025-05-23 | 6-K | 2025-05-23 | TRANSACTION IN OWN SHARES | a8763j.htm |
| 2025-05-22 | 6-K | 2025-05-22 | TRANSACTION IN OWN SHARES | a6751j.htm |
| 2025-05-21 | 6-K | 2025-05-21 | TRANSACTION IN OWN SHARES | a4892j.htm |
| 2025-05-20 | 6-K | 2025-05-20 | DIRECTOR/PDMR SHAREHOLDING | a4298j.htm |
| 2025-05-20 | 6-K | 2025-05-20 | TRANSACTION IN OWN SHARES | a2914j.htm |
| 2025-05-19 | 6-K | 2025-05-19 | BLENREP FOR 2L+ MULTIPLE MYELOMA APPROVED IN JAPAN | a1837j.htm |
| 2025-05-19 | 6-K | 2025-05-19 | TRANSACTION IN OWN SHARES | a1002j.htm |
| 2025-05-16 | 6-K | 2025-05-16 | TRANSACTION IN OWN SHARES | a9158i.htm |
| 2025-05-15 | 6-K | 2025-05-15 | TRANSACTION IN OWN SHARES | a7218i.htm |
| 2025-05-14 | 6-K | 2025-05-14 | GSK TO ACQUIRE EFIMOSFERMIN | a6114i.htm |
| 2025-05-14 | 6-K | 2025-05-14 | TRANSACTION IN OWN SHARES | a5301i.htm |
| 2025-05-13 | 6-K | 2025-05-13 | DIRECTOR/PDMR SHAREHOLDING | a5058i.htm |
| 2025-05-13 | 6-K | 2025-05-13 | UPDATE ON BELRESTOTUG DEVELOPMENT PROGRAMME | a4515i.htm |
| 2025-05-13 | 6-K | 2025-05-13 | TRANSACTION IN OWN SHARES | a3437i.htm |
| 2025-05-12 | 6-K | 2025-05-12 | BLOCK LISTING INTERIM REVIEW | a3210i.htm |
| 2025-05-12 | 6-K | 2025-05-12 | TRANSACTION IN OWN SHARES | a1547i.htm |
| 2025-05-09 | 6-K | 2025-05-09 | TRANSACTION IN OWN SHARES | a9697h.htm |
| 2025-05-08 | 6-K | 2025-05-08 | DIRECTOR/PDMR SHAREHOLDING | a9632h.htm |
| 2025-05-08 | 6-K | 2025-05-08 | DIRECTOR/PDMR SHAREHOLDING | a9461h.htm |
| 2025-05-08 | 6-K | 2025-05-08 | LINERIXIBAT GLISTEN PIII TRIAL DATA AT EASL | a8792h.htm |
| 2025-05-08 | 6-K | 2025-05-08 | TRANSACTION IN OWN SHARES | a7751h.htm |
| 2025-05-07 | 6-K | 2025-05-07 | RESULT OF AGM | a7756h.htm |
| 2025-05-07 | 6-K | 2025-05-07 | TRANSACTION IN OWN SHARES | a5735h.htm |
| 2025-05-06 | 6-K | 2025-05-06 | TRANSACTION IN OWN SHARES | a3287h.htm |
| 2025-05-02 | 6-K | 2025-05-02 | TRANSACTION IN OWN SHARES | a1461h.htm |
| 2025-05-01 | 6-K | 2025-05-01 | DIRECTOR/PDMR SHAREHOLDING | a1216h.htm |
| 2025-05-01 | 6-K | 2025-05-01 | TOTAL VOTING RIGHTS | a1171h.htm |
| 2025-05-01 | 6-K | 2025-05-01 | NUCALA MATINEE DATA IN COPD PUBLISHED IN NEJM | a9395g.htm |
| 2025-05-01 | 6-K | 2025-05-01 | TRANSACTION IN OWN SHARES | a9260g.htm |
| 2025-04-30 | 6-K | 2025-04-30 | TRANSACTION IN OWN SHARES | a7057g.htm |
| 2025-04-30 | 6-K | 2025-04-30 | 1ST QUARTER RESULTS | a7053g-59446108resubmissi.htm |
| 2025-04-29 | 6-K | 2025-04-29 | TRANSACTION IN OWN SHARES | a5240g.htm |
| 2025-04-28 | 6-K | 2025-04-28 | TRANSACTION IN OWN SHARES | a3200g.htm |
| 2025-04-25 | 6-K | 2025-04-25 | TRANSACTION IN OWN SHARES | a1301g.htm |
| 2025-04-24 | 6-K | 2025-04-24 | TRANSACTION IN OWN SHARES | a9366f.htm |
| 2025-04-23 | 6-K | 2025-04-23 | TRANSACTION IN OWN SHARES | a7476f.htm |
| 2025-04-22 | 6-K | 2025-04-22 | TRANSACTION IN OWN SHARES | a5464f.htm |
| 2025-04-17 | 6-K | 2025-04-17 | BLENREP LICENSED BY UK MHRA | a5283f.htm |
| 2025-04-17 | 6-K | 2025-04-17 | DIRECTOR/PDMR SHAREHOLDING | a5227f.htm |
| 2025-04-17 | 6-K | 2025-04-17 | AREXVY NOW ACIP RECOMMENDED FOR 50-59 AT RIS | a3702f.htm |
| 2025-04-17 | 6-K | 2025-04-17 | GSK 5-IN-1 MENINGITIS VACCINE RECOMMENDED IN US | a3700f.htm |
| 2025-04-17 | 6-K | 2025-04-17 | TRANSACTION IN OWN SHARES | a3620f.htm |
| 2025-04-16 | 6-K | 2025-04-16 | TRANSACTION IN OWN SHARES | a1851f.htm |
| 2025-04-15 | 6-K | 2025-04-15 | DIRECTOR/PDMR SHAREHOLDING | a1536f.htm |
| 2025-04-15 | 6-K | 2025-04-15 | TRANSACTION IN OWN SHARES | a9804e.htm |
| 2025-04-14 | 6-K | 2025-04-14 | DIRECTOR/PDMR SHAREHOLDING | a9569e.htm |
| 2025-04-14 | 6-K | 2025-04-14 | TRANSACTION IN OWN SHARES | a7865e.htm |
| 2025-04-11 | 6-K | 2025-04-11 | DIRECTOR/PDMR SHAREHOLDING | a7602e.htm |
| 2025-04-11 | 6-K | 2025-04-11 | TRANSACTION IN OWN SHARES | a5950e.htm |
| 2025-04-10 | 6-K | 2025-04-10 | TRANSACTION IN OWN SHARES | a4051e.htm |
| 2025-04-09 | 6-K | 2025-04-09 | TRANSACTION IN OWN SHARES | a2064e.htm |
| 2025-04-08 | 6-K | 2025-04-08 | TRANSACTION IN OWN SHARES | a0007e.htm |
| 2025-04-07 | 6-K | 2025-04-07 | TRANSACTION IN OWN SHARES | a8072d.htm |
| 2025-04-04 | 6-K | 2025-04-04 | TRANSACTION IN OWN SHARES | a6959d.htm |
| 2025-04-03 | 6-K | 2025-04-03 | TRANSACTION IN OWN SHARES | a4281d.htm |
| 2025-04-02 | 6-K | 2025-04-02 | TRANSACTION IN OWN SHARES | a2381d.htm |
| 2025-04-01 | 6-K | 2025-04-01 | TOTAL VOTING RIGHTS | a1851d.htm |
| 2025-04-01 | 6-K | 2025-04-01 | TRANSACTION IN OWN SHARES | a0151d.htm |
| 2025-03-31 | 6-K | 2025-03-31 | TRANSACTION IN OWN SHARES | a7890c.htm |
| 2025-03-28 | 6-K | 2025-03-28 | DIRECTOR/PDMR SHAREHOLDING | a5853c.htm |
| 2025-03-28 | 6-K | 2025-03-28 | TRANSACTION IN OWN SHARES | a5878c.htm |
| 2025-03-27 | 6-K | 2025-03-27 | TRANSACTION IN OWN SHARES | a3878c.htm |
| 2025-03-26 | 6-K | 2025-03-26 | TRANSACTION IN OWN SHARES | a1381c.htm |
| 2025-03-25 | 6-K | 2025-03-25 | GSK UUTI TREATMENT APPROVED BY US FDA | a1205c.htm |
| 2025-03-25 | 6-K | 2025-03-25 | TRANSACTION IN OWN SHARES | a9537b.htm |
| 2025-03-24 | 6-K | 2025-03-24 | NOTICE OF AGM | a9323b.htm |
| 2025-03-24 | 6-K | 2025-03-24 | EMA FILING ACCEPTANCE FOR NUCALA COPD | a8333b.htm |
| 2025-03-24 | 6-K | 2025-03-24 | TRANSACTION IN OWN SHARES | a7562b.htm |
| 2025-03-21 | 6-K | 2025-03-21 | DIRECTOR/PDMR SHAREHOLDING | a7340b.htm |
| 2025-03-21 | 6-K | 2025-03-21 | TRANSACTION IN OWN SHARES | a5728b.htm |
| 2025-03-20 | 6-K | 2025-03-20 | TRANSACTION IN OWN SHARES | a3797b.htm |
| 2025-03-19 | 6-K | 2025-03-19 | TRANSACTION IN OWN SHARES | a1975b.htm |
| 2025-03-18 | 6-K | 2025-03-18 | TRANSACTION IN OWN SHARES | a0191b.htm |
| 2025-03-17 | 6-K | 2025-03-17 | TRANSACTION IN OWN SHARES | a8265a.htm |
| 2025-03-14 | 6-K | 2025-03-14 | DIRECTOR/PDMR SHAREHOLDING | a7757a.htm |
| 2025-03-14 | 6-K | 2025-03-14 | TRANSACTION IN OWN SHARES | a7168a.htm |
| 2025-03-13 | 6-K | 2025-03-13 | TRANSACTION IN OWN SHARES | a4537a.htm |
| 2025-03-13 | 6-K | 2025-03-13 | 6-K | d923957d6k.htm |
| 2025-03-12 | 6-K | 2025-03-12 | TRANSACTION IN OWN SHARES | a2703a.htm |
| 2025-03-11 | 6-K | 2025-03-11 | TRANSACTION IN OWN SHARES | a0861a.htm |
| 2025-03-10 | 6-K | 2025-03-10 | TRANSACTION IN OWN SHARES | a9033z.htm |
| 2025-03-07 | 6-K | 2025-03-07 | TRANSACTION IN OWN SHARES | a7284z.htm |